IBDEI0A7 ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13535,2)
 ;;=^64849
 ;;^UTILITY(U,$J,358.3,13536,0)
 ;;=576.1^^88^797^5
 ;;^UTILITY(U,$J,358.3,13536,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13536,1,1,0)
 ;;=1^576.1
 ;;^UTILITY(U,$J,358.3,13536,1,2,0)
 ;;=2^CHOLANGITIS
 ;;^UTILITY(U,$J,358.3,13536,2)
 ;;=^23291
 ;;^UTILITY(U,$J,358.3,13537,0)
 ;;=574.70^^88^797^6
 ;;^UTILITY(U,$J,358.3,13537,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13537,1,1,0)
 ;;=1^574.70
 ;;^UTILITY(U,$J,358.3,13537,1,2,0)
 ;;=2^CHOLECYSTITIS W/CAL GB & BD
 ;;^UTILITY(U,$J,358.3,13537,2)
 ;;=^304314
 ;;^UTILITY(U,$J,358.3,13538,0)
 ;;=571.2^^88^797^7
 ;;^UTILITY(U,$J,358.3,13538,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13538,1,1,0)
 ;;=1^571.2
 ;;^UTILITY(U,$J,358.3,13538,1,2,0)
 ;;=2^CIRRHOSIS,ALCOHOLIC
 ;;^UTILITY(U,$J,358.3,13538,2)
 ;;=^71505
 ;;^UTILITY(U,$J,358.3,13539,0)
 ;;=571.5^^88^797^8
 ;;^UTILITY(U,$J,358.3,13539,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13539,1,1,0)
 ;;=1^571.5
 ;;^UTILITY(U,$J,358.3,13539,1,2,0)
 ;;=2^CIRRHOSIS,NON-ALCOHOLIC
 ;;^UTILITY(U,$J,358.3,13539,2)
 ;;=^24731
 ;;^UTILITY(U,$J,358.3,13540,0)
 ;;=555.9^^88^797^9
 ;;^UTILITY(U,$J,358.3,13540,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13540,1,1,0)
 ;;=1^555.9
 ;;^UTILITY(U,$J,358.3,13540,1,2,0)
 ;;=2^CROHN'S DISEASE
 ;;^UTILITY(U,$J,358.3,13540,2)
 ;;=^29356
 ;;^UTILITY(U,$J,358.3,13541,0)
 ;;=578.9^^88^797^10
 ;;^UTILITY(U,$J,358.3,13541,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13541,1,1,0)
 ;;=1^578.9
 ;;^UTILITY(U,$J,358.3,13541,1,2,0)
 ;;=2^GASTROINTEST HEMORR NOS
 ;;^UTILITY(U,$J,358.3,13541,2)
 ;;=^49525
 ;;^UTILITY(U,$J,358.3,13542,0)
 ;;=572.2^^88^797^11
 ;;^UTILITY(U,$J,358.3,13542,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13542,1,1,0)
 ;;=1^572.2
 ;;^UTILITY(U,$J,358.3,13542,1,2,0)
 ;;=2^HEPATIC ENCEPHALOPATHY
 ;;^UTILITY(U,$J,358.3,13542,2)
 ;;=^338527
 ;;^UTILITY(U,$J,358.3,13543,0)
 ;;=573.4^^88^797^12
 ;;^UTILITY(U,$J,358.3,13543,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13543,1,1,0)
 ;;=1^573.4
 ;;^UTILITY(U,$J,358.3,13543,1,2,0)
 ;;=2^HEPATIC INFARCTION
 ;;^UTILITY(U,$J,358.3,13543,2)
 ;;=^276862
 ;;^UTILITY(U,$J,358.3,13544,0)
 ;;=570.^^88^797^13
 ;;^UTILITY(U,$J,358.3,13544,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13544,1,1,0)
 ;;=1^570.
 ;;^UTILITY(U,$J,358.3,13544,1,2,0)
 ;;=2^HEPATIC NECROSIS
 ;;^UTILITY(U,$J,358.3,13544,2)
 ;;=^2603
 ;;^UTILITY(U,$J,358.3,13545,0)
 ;;=572.4^^88^797^14
 ;;^UTILITY(U,$J,358.3,13545,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13545,1,1,0)
 ;;=1^572.4
 ;;^UTILITY(U,$J,358.3,13545,1,2,0)
 ;;=2^HEPATORENAL SYNDROME
 ;;^UTILITY(U,$J,358.3,13545,2)
 ;;=^56497
 ;;^UTILITY(U,$J,358.3,13546,0)
 ;;=557.9^^88^797^15
 ;;^UTILITY(U,$J,358.3,13546,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13546,1,1,0)
 ;;=1^557.9
 ;;^UTILITY(U,$J,358.3,13546,1,2,0)
 ;;=2^INTEST ISCHEMIA & INFARCTION
 ;;^UTILITY(U,$J,358.3,13546,2)
 ;;=^270252
 ;;^UTILITY(U,$J,358.3,13547,0)
 ;;=577.0^^88^797^16
 ;;^UTILITY(U,$J,358.3,13547,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13547,1,1,0)
 ;;=1^577.0
 ;;^UTILITY(U,$J,358.3,13547,1,2,0)
 ;;=2^PANCREATITIS
 ;;^UTILITY(U,$J,358.3,13547,2)
 ;;=^2643
 ;;^UTILITY(U,$J,358.3,13548,0)
 ;;=567.9^^88^797^17
 ;;^UTILITY(U,$J,358.3,13548,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13548,1,1,0)
 ;;=1^567.9
 ;;^UTILITY(U,$J,358.3,13548,1,2,0)
 ;;=2^PERITONITIS NOS
 ;;^UTILITY(U,$J,358.3,13548,2)
 ;;=^92323
 ;;^UTILITY(U,$J,358.3,13549,0)
 ;;=452.^^88^797^18
 ;;^UTILITY(U,$J,358.3,13549,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13549,1,1,0)
 ;;=1^452.
 ;;^UTILITY(U,$J,358.3,13549,1,2,0)
 ;;=2^PORTAL VEIN THROMBOSIS
 ;;^UTILITY(U,$J,358.3,13549,2)
 ;;=^269815
 ;;^UTILITY(U,$J,358.3,13550,0)
 ;;=556.9^^88^797^19
 ;;^UTILITY(U,$J,358.3,13550,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13550,1,1,0)
 ;;=1^556.9
 ;;^UTILITY(U,$J,358.3,13550,1,2,0)
 ;;=2^ULCERATIVE COLITIS
 ;;^UTILITY(U,$J,358.3,13550,2)
 ;;=^26044
 ;;^UTILITY(U,$J,358.3,13551,0)
 ;;=569.9^^88^797^20
 ;;^UTILITY(U,$J,358.3,13551,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13551,1,1,0)
 ;;=1^569.9
 ;;^UTILITY(U,$J,358.3,13551,1,2,0)
 ;;=2^OTHER INTESTINAL COND
 ;;^UTILITY(U,$J,358.3,13551,2)
 ;;=^123842
 ;;^UTILITY(U,$J,358.3,13552,0)
 ;;=573.9^^88^797^21
 ;;^UTILITY(U,$J,358.3,13552,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13552,1,1,0)
 ;;=1^573.9
 ;;^UTILITY(U,$J,358.3,13552,1,2,0)
 ;;=2^OTHER LIVER DISEASE
 ;;^UTILITY(U,$J,358.3,13552,2)
 ;;=^123854
 ;;^UTILITY(U,$J,358.3,13553,0)
 ;;=580.9^^88^798^1
 ;;^UTILITY(U,$J,358.3,13553,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13553,1,1,0)
 ;;=1^580.9
 ;;^UTILITY(U,$J,358.3,13553,1,2,0)
 ;;=2^ACUTE GLOMERULONEPHRITIS
 ;;^UTILITY(U,$J,358.3,13553,2)
 ;;=^270342
 ;;^UTILITY(U,$J,358.3,13554,0)
 ;;=584.9^^88^798^2
 ;;^UTILITY(U,$J,358.3,13554,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13554,1,1,0)
 ;;=1^584.9
 ;;^UTILITY(U,$J,358.3,13554,1,2,0)
 ;;=2^ACUTE RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,13554,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,13555,0)
 ;;=582.9^^88^798^3
 ;;^UTILITY(U,$J,358.3,13555,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13555,1,1,0)
 ;;=1^582.9
 ;;^UTILITY(U,$J,358.3,13555,1,2,0)
 ;;=2^CHRONIC GLOMERULONEPHRITIS
 ;;^UTILITY(U,$J,358.3,13555,2)
 ;;=^270351
 ;;^UTILITY(U,$J,358.3,13556,0)
 ;;=585.9^^88^798^4
 ;;^UTILITY(U,$J,358.3,13556,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13556,1,1,0)
 ;;=1^585.9
 ;;^UTILITY(U,$J,358.3,13556,1,2,0)
 ;;=2^CHRONIC KIDNEY DISEASE
 ;;^UTILITY(U,$J,358.3,13556,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,13557,0)
 ;;=586.^^88^798^5
 ;;^UTILITY(U,$J,358.3,13557,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13557,1,1,0)
 ;;=1^586.
 ;;^UTILITY(U,$J,358.3,13557,1,2,0)
 ;;=2^OTHER RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,13557,2)
 ;;=^104733
 ;;^UTILITY(U,$J,358.3,13558,0)
 ;;=694.9^^88^799^1
 ;;^UTILITY(U,$J,358.3,13558,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13558,1,1,0)
 ;;=1^694.9
 ;;^UTILITY(U,$J,358.3,13558,1,2,0)
 ;;=2^BULLOUS DERMATOSES NOS
 ;;^UTILITY(U,$J,358.3,13558,2)
 ;;=^187900
 ;;^UTILITY(U,$J,358.3,13559,0)
 ;;=695.10^^88^799^2
 ;;^UTILITY(U,$J,358.3,13559,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13559,1,1,0)
 ;;=1^695.10
 ;;^UTILITY(U,$J,358.3,13559,1,2,0)
 ;;=2^ERYTHEMA MULTIFORME NOS
 ;;^UTILITY(U,$J,358.3,13559,2)
 ;;=^336759
 ;;^UTILITY(U,$J,358.3,13560,0)
 ;;=696.1^^88^799^3
 ;;^UTILITY(U,$J,358.3,13560,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13560,1,1,0)
 ;;=1^696.1
 ;;^UTILITY(U,$J,358.3,13560,1,2,0)
 ;;=2^PSORIASIS
 ;;^UTILITY(U,$J,358.3,13560,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,13561,0)
 ;;=695.81^^88^799^4
 ;;^UTILITY(U,$J,358.3,13561,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13561,1,1,0)
 ;;=1^695.81
 ;;^UTILITY(U,$J,358.3,13561,1,2,0)
 ;;=2^STAPHLYCOCCAL SCALED SKIN SYND
 ;;^UTILITY(U,$J,358.3,13561,2)
 ;;=^113858
 ;;^UTILITY(U,$J,358.3,13562,0)
 ;;=695.13^^88^799^5
 ;;^UTILITY(U,$J,358.3,13562,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13562,1,1,0)
 ;;=1^695.13
 ;;^UTILITY(U,$J,358.3,13562,1,2,0)
 ;;=2^STEVENS-JOHNSON SYNDROME
 ;;^UTILITY(U,$J,358.3,13562,2)
 ;;=^336636
 ;;^UTILITY(U,$J,358.3,13563,0)
 ;;=695.15^^88^799^6
 ;;^UTILITY(U,$J,358.3,13563,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13563,1,1,0)
 ;;=1^695.15
 ;;^UTILITY(U,$J,358.3,13563,1,2,0)
 ;;=2^TOXIC EPIDRML NECROLYSIS
 ;;^UTILITY(U,$J,358.3,13563,2)
 ;;=^336638
 ;;^UTILITY(U,$J,358.3,13564,0)
 ;;=695.9^^88^799^7
 ;;^UTILITY(U,$J,358.3,13564,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13564,1,1,0)
 ;;=1^695.9
 ;;^UTILITY(U,$J,358.3,13564,1,2,0)
 ;;=2^OTHER ERYTHEMATOUS SKIN COND
 ;;^UTILITY(U,$J,358.3,13564,2)
 ;;=^123902
 ;;^UTILITY(U,$J,358.3,13565,0)
 ;;=441.9^^88^800^2
 ;;^UTILITY(U,$J,358.3,13565,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13565,1,1,0)
 ;;=1^441.9
 ;;^UTILITY(U,$J,358.3,13565,1,2,0)
 ;;=2^ANEURYSM,AORTIC W/O RUPTURE
 ;;^UTILITY(U,$J,358.3,13565,2)
 ;;=^9277
 ;;^UTILITY(U,$J,358.3,13566,0)
 ;;=442.9^^88^800^3
 ;;^UTILITY(U,$J,358.3,13566,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13566,1,1,0)
 ;;=1^442.9
 ;;^UTILITY(U,$J,358.3,13566,1,2,0)
 ;;=2^ANEURYSM,NON-AORTIC
 ;;^UTILITY(U,$J,358.3,13566,2)
 ;;=^7390
 ;;^UTILITY(U,$J,358.3,13567,0)
 ;;=710.3^^88^800^4
 ;;^UTILITY(U,$J,358.3,13567,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13567,1,1,0)
 ;;=1^710.3
 ;;^UTILITY(U,$J,358.3,13567,1,2,0)
 ;;=2^DERMATOMYOSITIS
 ;;^UTILITY(U,$J,358.3,13567,2)
 ;;=^33162
 ;;^UTILITY(U,$J,358.3,13568,0)
 ;;=446.5^^88^800^5
 ;;^UTILITY(U,$J,358.3,13568,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13568,1,1,0)
 ;;=1^446.5
 ;;^UTILITY(U,$J,358.3,13568,1,2,0)
 ;;=2^GIANT CELL ARTERITIS
 ;;^UTILITY(U,$J,358.3,13568,2)
 ;;=^117658
 ;;^UTILITY(U,$J,358.3,13569,0)
 ;;=446.20^^88^800^6
 ;;^UTILITY(U,$J,358.3,13569,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13569,1,1,0)
 ;;=1^446.20
 ;;^UTILITY(U,$J,358.3,13569,1,2,0)
 ;;=2^HYPERSENSITIVITY ANGIITIS, UNS
 ;;^UTILITY(U,$J,358.3,13569,2)
 ;;=^60279
 ;;^UTILITY(U,$J,358.3,13570,0)
 ;;=446.3^^88^800^7
 ;;^UTILITY(U,$J,358.3,13570,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13570,1,1,0)
 ;;=1^446.3
 ;;^UTILITY(U,$J,358.3,13570,1,2,0)
 ;;=2^LETHAL MIDLINE GRANULOMA
 ;;^UTILITY(U,$J,358.3,13570,2)
 ;;=^52905
 ;;^UTILITY(U,$J,358.3,13571,0)
 ;;=446.1^^88^800^8
 ;;^UTILITY(U,$J,358.3,13571,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13571,1,1,0)
 ;;=1^446.1
 ;;^UTILITY(U,$J,358.3,13571,1,2,0)
 ;;=2^MUCOCUTANEOUS LYMPH SYND (MCLS)
 ;;^UTILITY(U,$J,358.3,13571,2)
 ;;=^79494
 ;;^UTILITY(U,$J,358.3,13572,0)
 ;;=443.9^^88^800^12
 ;;^UTILITY(U,$J,358.3,13572,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13572,1,1,0)
 ;;=1^443.9
 ;;^UTILITY(U,$J,358.3,13572,1,2,0)
 ;;=2^PERIPH VASCULAR DIS NOS
 ;;^UTILITY(U,$J,358.3,13572,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,13573,0)
 ;;=446.0^^88^800^13
 ;;^UTILITY(U,$J,358.3,13573,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,13573,1,1,0)
 ;;=1^446.0
